|
ZFAND6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.794000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.738300E-02 |
| Normal-vs-Stage2 |
9.368800E-01 |
| Normal-vs-Stage3 |
1.627250E-01 |
| Normal-vs-Stage4 |
1.209550E-02 |
| Stage1-vs-Stage2 |
3.639200E-01 |
| Stage1-vs-Stage3 |
8.803600E-01 |
| Stage1-vs-Stage4 |
1.813440E-01 |
| Stage2-vs-Stage3 |
4.374600E-01 |
| Stage2-vs-Stage4 |
1.014560E-01 |
| Stage3-vs-Stage4 |
1.882600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.146400E-02 |
| Normal-vs-AfricanAmerican |
2.930800E-01 |
| Normal-vs-Asian |
2.412800E-01 |
| Caucasian-vs-AfricanAmerican |
8.004800E-01 |
| Caucasian-vs-Asian |
7.969400E-01 |
| AfricanAmerican-vs-Asian |
9.581200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.677700E-02 |
| Normal-vs-Female |
1.004160E-01 |
| Male-vs-Female |
4.841600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.032200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.238400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.413400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.935800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.868200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.180800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.789400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.245400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.430600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.119200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.802400E-01 |
| Classical-VS-Follicular |
3.525900E-02 |
| Classical-VS-Other |
6.648000E-01 |
| Classical-VS-Normal |
3.837600E-02 |
| Tall-VS-Follicular |
3.988300E-02 |
| Tall-VS-Other |
8.842600E-01 |
| Tall-VS-Normal |
5.654000E-02 |
| Follicular-VS-Other |
3.599200E-01 |
| Follicular-VS-Normal |
5.578600E-01 |
| Other-VS-Normal |
1.959560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.876410E-01 |
| Normal-vs-N1 |
2.636800E-04 |
| N0-vs-N1 |
1.114320E-02 |
|
|
